The global reprocessed medical devices market accounted for USD 2.76 billion in 2023 and is expected to reach at USD 15.25 billion by 2034 with a CAGR of 16.81% during the forecast period 2024-2034. Rising demand to diminish medical waste in healthcare environments, greater recognition of the benefits of reusing devices, increasing incidence of cardiovascular diseases, growing elderly population, enhancements in healthcare facilities, government campaigns to endorse equipment reprocessing, heightened partnerships between leading hospitals & reprocessing firms, surge in chronic diseases, and surge in approval of reprocessed medical devices by regulatory authorities are the factors propelling the market growth.
Reprocessing a medical device involves sterilization, labeling, cleaning, disinfection, and refurbishing to ensure its safe reuse. However, the cleaning process must meet specific standards to enable the use of medical equipment without the risk of contamination. Hence, surge in approval of reprocessed medical devices by regulatory authorities is predicted to boost the market growth during the forecast period. For instance, in June 2023, Ohio-based medical technology firm Vein360 obtained FDA 510(k) clearance to reprocess the Philips Visions PV.035 digital intravascular ultrasound catheter.
By product, cardiovascular was the highest revenue-grossing segment in the global reprocessed medical devices market in 2023 owing to the surge in cardiovascular surgical procedures & therapies, growing number of FDA clearances for reprocessed cardiovascular devices. These include widely used products such as blood pressure cuffs, electrophysiology cables, blood pressure monitors, diagnostic electrophysiology catheters, all integral to cardiovascular surgeries and diagnostics. For instance, in May 2022, Innovative Health, LLC has obtained approval to reprocess the Philips Eagle Eye Platinum digital IVUS catheter, signaling the company's debut in the catheterization laboratory sector. This move extends the company's footprint in the cardiology segment of the medical device reprocessing market. Additionally, laparoscopy is predicted to grow at the fastest CAGR during the forecast period owing to the significant increase in waste production due to the use of disposable devices and rising preference for minimally invasive procedures.
By type, third-party reprocessing was the highest revenue-grossing segment in the global reprocessed medical devices market in 2023 owing to the rising initiatives by market players. Third-party entities receive previously used medical devices, which would otherwise be disposed of as medical waste, and employ diverse cleaning, sterilization, and refurbishment methods to prepare them for reuse. For instance, in November 2023, Medline Industries, LP., a privately-owned healthcare firm, revealed an expansion of its Redmond facility in the United States, dedicated to reprocessing medical items typically disposed of in landfills. The site's area has expanded by approximately 52,000 square feet. This expansion aligns with the company's initiative known as ReNewal, focusing on medical device reprocessing. Additionally, in-house reprocessing is predicted to grow at the fastest CAGR during the forecast period. In-house reprocessing entails healthcare facilities, such as hospitals, sterilizing and refurbishing medical devices for reuse within their own premises. In-house reprocessing involves cleaning, disinfecting, sterilizing, and testing previously used medical devices to ensure their safety for reuse. This process also encompasses the restoration of the device's technical and functional integrity.
By end-user, hospitals was the highest revenue-grossing segment in the global reprocessed medical devices market in 2023 owing to the increasing demand for reprocessed medical devices aims to cut down costs & minimize medical waste generated by conventional equipment, heightened collaboration among industry players. Beyond environmental concerns, healthcare leadership also emphasizes the quality of reprocessed devices. Research indicates that reused medical instruments can offer greater reliability compared to new ones. For instance, in January 2023, AA Medical, a company offering sustainable solutions in both new and resale medical device markets, has teamed up with Certified Endoscopy Products, a prominent Chicago-based company specializing in endoscopic devices. This partnership aims to address the increasing demand for medical device reprocessing in various surgical device markets, including endoscopy and orthopedics. Additionally, home healthcare is predicted to grow at the fastest CAGR during the forecast period owing to the growing opportunity to integrate reprocessed products into home healthcare due to the limited availability of home medical device providers and the increasing demand for affordable home equipment. Reprocessed home medical equipment, such as patient monitoring systems, orthopedic devices, and external support devices, contribute to improving the mobility of patients in their home environment.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing urgency to minimize hospital waste & mitigate environmental harm resulting from expanding waste landfills, surge in government initiatives, increase in strategic efforts by healthcare organizations to raise awareness about equipment reprocessing, and market players are introducing a greater number of reprocessed medical devices. For instance, in June 2023, Olympus unveiled the release of the new Olympus ETD, available in two versions: ETD Basic and ETD Premium. This latest addition to the company's Infection Prevention lineup was designed to enhance the efficiency and sustainability of endoscope reprocessing, while also delivering superior cleaning and disinfection outcomes. Healthcare professionals will appreciate the improved usability and simplified process, resulting in reduced workloads. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing incidence of chronic diseases, a heightened demand to control hospital expenditures, increase in government investment in healthcare infrastructure, and rise in the approval of reprocessed devices by regulatory authorities. For instance, in July 2022, NEScientific, Inc., specializing in reprocessing single-use peripheral vascular catheters, disclosed FDA clearance for reprocessing the Philips Spectranetics 0.9mm OTW Turbo-Elite laser atherectomy catheter. This device is employed in treating peripheral arterial disease (PAD) by utilizing high-energy ultraviolet light to eliminate blockages within blood vessels. The laser catheter is widely utilized in this procedure across various healthcare settings, including acute care facilities, surgical centers, and Office-based Labs (OBL).
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Reprocessing a medical device involves sterilization, labeling, cleaning, disinfection, and refurbishing to ensure its safe reuse. However, the cleaning process must meet specific standards to enable the use of medical equipment without the risk of contamination. Hence, surge in approval of reprocessed medical devices by regulatory authorities is predicted to boost the market growth during the forecast period. For instance, in June 2023, Ohio-based medical technology firm Vein360 obtained FDA 510(k) clearance to reprocess the Philips Visions PV.035 digital intravascular ultrasound catheter.
By product, cardiovascular was the highest revenue-grossing segment in the global reprocessed medical devices market in 2023 owing to the surge in cardiovascular surgical procedures & therapies, growing number of FDA clearances for reprocessed cardiovascular devices. These include widely used products such as blood pressure cuffs, electrophysiology cables, blood pressure monitors, diagnostic electrophysiology catheters, all integral to cardiovascular surgeries and diagnostics. For instance, in May 2022, Innovative Health, LLC has obtained approval to reprocess the Philips Eagle Eye Platinum digital IVUS catheter, signaling the company's debut in the catheterization laboratory sector. This move extends the company's footprint in the cardiology segment of the medical device reprocessing market. Additionally, laparoscopy is predicted to grow at the fastest CAGR during the forecast period owing to the significant increase in waste production due to the use of disposable devices and rising preference for minimally invasive procedures.
By type, third-party reprocessing was the highest revenue-grossing segment in the global reprocessed medical devices market in 2023 owing to the rising initiatives by market players. Third-party entities receive previously used medical devices, which would otherwise be disposed of as medical waste, and employ diverse cleaning, sterilization, and refurbishment methods to prepare them for reuse. For instance, in November 2023, Medline Industries, LP., a privately-owned healthcare firm, revealed an expansion of its Redmond facility in the United States, dedicated to reprocessing medical items typically disposed of in landfills. The site's area has expanded by approximately 52,000 square feet. This expansion aligns with the company's initiative known as ReNewal, focusing on medical device reprocessing. Additionally, in-house reprocessing is predicted to grow at the fastest CAGR during the forecast period. In-house reprocessing entails healthcare facilities, such as hospitals, sterilizing and refurbishing medical devices for reuse within their own premises. In-house reprocessing involves cleaning, disinfecting, sterilizing, and testing previously used medical devices to ensure their safety for reuse. This process also encompasses the restoration of the device's technical and functional integrity.
By end-user, hospitals was the highest revenue-grossing segment in the global reprocessed medical devices market in 2023 owing to the increasing demand for reprocessed medical devices aims to cut down costs & minimize medical waste generated by conventional equipment, heightened collaboration among industry players. Beyond environmental concerns, healthcare leadership also emphasizes the quality of reprocessed devices. Research indicates that reused medical instruments can offer greater reliability compared to new ones. For instance, in January 2023, AA Medical, a company offering sustainable solutions in both new and resale medical device markets, has teamed up with Certified Endoscopy Products, a prominent Chicago-based company specializing in endoscopic devices. This partnership aims to address the increasing demand for medical device reprocessing in various surgical device markets, including endoscopy and orthopedics. Additionally, home healthcare is predicted to grow at the fastest CAGR during the forecast period owing to the growing opportunity to integrate reprocessed products into home healthcare due to the limited availability of home medical device providers and the increasing demand for affordable home equipment. Reprocessed home medical equipment, such as patient monitoring systems, orthopedic devices, and external support devices, contribute to improving the mobility of patients in their home environment.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing urgency to minimize hospital waste & mitigate environmental harm resulting from expanding waste landfills, surge in government initiatives, increase in strategic efforts by healthcare organizations to raise awareness about equipment reprocessing, and market players are introducing a greater number of reprocessed medical devices. For instance, in June 2023, Olympus unveiled the release of the new Olympus ETD, available in two versions: ETD Basic and ETD Premium. This latest addition to the company's Infection Prevention lineup was designed to enhance the efficiency and sustainability of endoscope reprocessing, while also delivering superior cleaning and disinfection outcomes. Healthcare professionals will appreciate the improved usability and simplified process, resulting in reduced workloads. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing incidence of chronic diseases, a heightened demand to control hospital expenditures, increase in government investment in healthcare infrastructure, and rise in the approval of reprocessed devices by regulatory authorities. For instance, in July 2022, NEScientific, Inc., specializing in reprocessing single-use peripheral vascular catheters, disclosed FDA clearance for reprocessing the Philips Spectranetics 0.9mm OTW Turbo-Elite laser atherectomy catheter. This device is employed in treating peripheral arterial disease (PAD) by utilizing high-energy ultraviolet light to eliminate blockages within blood vessels. The laser catheter is widely utilized in this procedure across various healthcare settings, including acute care facilities, surgical centers, and Office-based Labs (OBL).
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Type, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Reprocessed Medical Devices Market Report 2023 - 2034
Reprocessed Medical Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Orthopedic Devices
- Gastroenterology
- Biopsy Forceps
- Others
- Laparoscopic
- Endoscopic Trocars
- Harmonic Scalpels
- General Surgery Devices
- Pressure Bags
- Balloon Inflation Devices
- Cardiovascular
- Positioning Devices
- Blood Pressure Cuffs
- Electrophysiology Cables
- Cardiac Stabilization Devices
- Diagnostic Electrophysiology Catheters
- Deep Vein Thrombosis Compression Sleeves
Reprocessed Medical Devices Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- In-house Reprocessing
- Third-party Reprocessing
Reprocessed Medical Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Home Healthcare
- Hospitals
- Others
Reprocessed Medical Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Reprocessed Medical Devices Market: Product Estimates & Trend Analysis
8. Reprocessed Medical Devices Market: Type Estimates & Trend Analysis
9. Reprocessed Medical Devices Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Reprocessed Medical Devices Market
12. Europe Global Reprocessed Medical Devices Market
13. Asia Pacific Global Reprocessed Medical Devices Market
14. Latin America Global Reprocessed Medical Devices Market
15. MEA Global Reprocessed Medical Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Arjo
- Stryker
- Vanguard AG
- Soma Tech Intl
- Cardinal Health
- NEScientific Inc.
- SureTek Medical
- Innovative Health
- Medline Industries
- LP.
- Johnson & Johnson MedTech
